|
WO1999038845A1
(en)
|
1998-01-29 |
1999-08-05 |
Tularik Inc. |
Ppar-gamma modulators
|
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
|
EP2324825A1
(en)
|
2002-02-11 |
2011-05-25 |
Bayer Healthcare LLC |
Aryl ureas with angiogenesis inhibiting activity
|
|
EP2270006A1
(en)
|
2002-08-08 |
2011-01-05 |
Amgen, Inc |
Pyridazine derivatives useful as vanilloid receptor ligands
|
|
ATE527250T1
(de)
|
2002-11-21 |
2011-10-15 |
Novartis Ag |
2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7279576B2
(en)
|
2002-12-31 |
2007-10-09 |
Deciphera Pharmaceuticals, Llc |
Anti-cancer medicaments
|
|
US20050014753A1
(en)
|
2003-04-04 |
2005-01-20 |
Irm Llc |
Novel compounds and compositions as protein kinase inhibitors
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
JP5020073B2
(ja)
|
2004-06-18 |
2012-09-05 |
ミレニアム ファーマシューティカルズ インク． |
第Ｘａ因子阻害剤
|
|
GB0415364D0
(en)
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
CA2579143A1
(en)
|
2004-09-13 |
2006-03-23 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
JP2008516989A
(ja)
|
2004-10-19 |
2008-05-22 |
コンパス ファーマシューティカルズ リミティド ライアビリティ カンパニー |
組成物及び抗腫瘍剤としてのその使用
|
|
US20090239841A1
(en)
|
2004-10-27 |
2009-09-24 |
Hutchison Alan J |
Diaryl Ureas as CB1 Antagonists
|
|
WO2006071940A2
(en)
|
2004-12-23 |
2006-07-06 |
Deciphera Pharmaceuticals, Llc |
Enzyme modulators and treatments
|
|
BRPI0519424B8
(pt)
|
2004-12-28 |
2021-05-25 |
Athenex Inc |
compostos, composição e uso dos ditos compostos para a preparação de um medicamento para prevenção ou tratamento de um distúrbio de proliferação celular ou infecção microbiana
|
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
|
AR053712A1
(es)
|
2005-04-18 |
2007-05-16 |
Neurogen Corp |
Heteroarilos sustituidos, antagonistas de cb1 (receptor 1 canabinoide)
|
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
GB0625659D0
(en)
|
2006-12-21 |
2007-01-31 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
CA2684950A1
(en)
|
2007-04-20 |
2008-10-30 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
US8343966B2
(en)
|
2008-01-11 |
2013-01-01 |
Novartis Ag |
Organic compounds
|
|
EA201100136A1
(ru)
|
2008-06-13 |
2011-08-30 |
Новартис Аг |
2,4'-бипиридинилы в качестве ингибиторов протеинкиназы d, применимые для лечения сердечной недостаточности и рака
|
|
CN102256493A
(zh)
|
2008-10-29 |
2011-11-23 |
迪赛孚尔制药有限公司 |
表现出抗癌活性和抗增殖活性的环丙烷酰胺及其类似物
|
|
EP2542536B1
(en)
|
2010-03-04 |
2015-01-21 |
Cellzome Limited |
Morpholino substituted urea derivatives as mtor inhibitors
|
|
DK2563362T3
(da)
|
2010-04-29 |
2014-06-23 |
Deciphera Pharmaceuticals Llc |
Cyclopropyldicarboxamider og analoger heraf, der udviser anticancer og antiproliferativ aktivitet
|
|
US8569319B2
(en)
|
2010-04-29 |
2013-10-29 |
Deciphera Pharmaceuticals, LLS |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
MX2014006126A
(es)
|
2011-11-22 |
2015-03-19 |
Deciphera Pharmaceuticals Llc |
Amidas de piridona y analogos que exhiben actividades anticancerigenas y antiproliferativas.
|
|
US9187474B2
(en)
|
2012-03-07 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Raf inhibitor compounds
|
|
AR090151A1
(es)
|
2012-03-07 |
2014-10-22 |
Lilly Co Eli |
Compuestos inhibidores de raf
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
WO2014145023A1
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
EP2968286B1
(en)
|
2013-03-15 |
2017-09-13 |
Deciphera Pharmaceuticals, LLC |
2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
CN110563700A
(zh)
|
2013-03-15 |
2019-12-13 |
德西费拉制药有限责任公司 |
展现抗癌和抗增殖活性的n-酰基-n′-(吡啶-2-基)脲及类似物
|
|
US9309224B2
(en)
|
2013-03-15 |
2016-04-12 |
Deciphera Pharmaceuticals, Llc. |
N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
US9012635B2
(en)
|
2013-03-15 |
2015-04-21 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2014145015A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
JP6371851B2
(ja)
|
2013-08-27 |
2018-08-08 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｉｄｏ阻害剤
|
|
KR20160063366A
(ko)
|
2013-10-21 |
2016-06-03 |
메르크 파텐트 게엠베하 |
Btk 저해제로서 헤테로아릴 화합물 및 이들의 용도
|
|
WO2015059618A1
(en)
|
2013-10-22 |
2015-04-30 |
Glenmark Pharmaceuticals S.A. |
SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS
|
|
US9457019B2
(en)
|
2013-11-07 |
2016-10-04 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
|
|
CN106061480B
(zh)
|
2013-12-30 |
2020-02-28 |
莱福斯希医药公司 |
治疗性抑制性化合物
|
|
WO2015108861A1
(en)
|
2014-01-14 |
2015-07-23 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
WO2016038582A1
(en)
|
2014-09-12 |
2016-03-17 |
Novartis Ag |
Compounds and compositions as raf kinase inhibitors
|
|
WO2018104307A1
(en)
|
2016-12-09 |
2018-06-14 |
Bayer Pharma Aktiengesellschaft |
Aromatic sulfonamide derivatives and their use as anatagon i sts or negative allosteric modulators of p2x4
|
|
KR102794891B1
(ko)
|
2017-05-30 |
2025-04-15 |
데시페라 파마슈티칼스, 엘엘씨 |
혈소판 유래 성장 인자 수용체 알파의 유전적 이상과 연관된 암 치료를 위한 1-[4-브로모-5-[1-에틸-7-(메틸아미노)-2-옥소-1,2-다이히드로-1,6-나프티리딘-3-일]-2-플루오로페닐]-3-페닐우레아 및 유사체의 용도
|
|
JP2021512160A
(ja)
|
2018-01-29 |
2021-05-13 |
カピュラス セラピューティクス リミテッド ライアビリティ カンパニー |
６員の中央環を含むｓｒｅｂｐ阻害剤
|
|
EP3746059B1
(en)
|
2018-01-31 |
2026-03-04 |
Deciphera Pharmaceuticals, LLC |
Combination therapy for the treatment of gastrointestinal stromal tumors
|
|
AU2019216351B2
(en)
|
2018-01-31 |
2024-07-25 |
Deciphera Pharmaceuticals, Llc |
Combination therapy for the treatment of mastocytosis
|
|
AU2019251360B2
(en)
|
2018-04-10 |
2025-03-13 |
Neuropore Therapies, Inc. |
Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways
|
|
US11945803B2
(en)
|
2018-08-07 |
2024-04-02 |
Tosk, Inc. |
Modulators of RAS GTPase
|
|
KR20210119411A
(ko)
|
2018-12-28 |
2021-10-05 |
데시페라 파마슈티칼스, 엘엘씨. |
암 치료에 사용하기 위한 csf1r 억제제
|
|
CN113874381A
(zh)
|
2019-03-22 |
2021-12-31 |
金耐特生物制药公司 |
Raf激酶的抑制剂
|
|
EP3966207B1
(en)
|
2019-05-10 |
2023-11-01 |
Deciphera Pharmaceuticals, LLC |
Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
|
|
EP3966206B1
(en)
|
2019-05-10 |
2023-08-09 |
Deciphera Pharmaceuticals, LLC |
Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
|
|
ES3025633T3
(en)
|
2019-05-13 |
2025-06-09 |
Novartis Ag |
New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer
|
|
US11266643B2
(en)
|
2019-05-15 |
2022-03-08 |
Chemocentryx, Inc. |
Triaryl compounds for treatment of PD-L1 diseases
|
|
JP7626722B2
(ja)
|
2019-06-17 |
2025-02-04 |
デシフェラ・ファーマシューティカルズ，エルエルシー |
アミノピリミジンアミドオートファジー阻害剤およびその使用方法
|
|
TWI878335B
(zh)
|
2019-08-12 |
2025-04-01 |
美商迪賽孚爾製藥有限公司 |
治療胃腸道基質瘤方法
|
|
US20230277522A9
(en)
|
2019-08-12 |
2023-09-07 |
Deciphera Pharmaceuticals, Llc |
Methods for treating vascular malformations
|
|
FI4013412T3
(fi)
|
2019-08-12 |
2026-03-24 |
Deciphera Pharmaceuticals Llc |
Ripretinibi ruoansulatuskanavan stroomakasvaimien hoitoon
|
|
BR112022007612A2
(pt)
|
2019-10-24 |
2022-09-20 |
Kinnate Biopharma Inc |
Inibidores de raf quinases
|
|
EP4071146A4
(en)
|
2019-12-06 |
2023-01-04 |
Medshine Discovery Inc. |
BIARYL COMPOUND AS PAN-RAF KINASE INHIBITOR
|
|
AU2020419197B2
(en)
|
2019-12-30 |
2023-08-31 |
Deciphera Pharmaceuticals, Llc |
Amorphous kinase inhibitor formulations and methods of use thereof
|
|
PL4084779T3
(pl)
|
2019-12-30 |
2025-02-24 |
Deciphera Pharmaceuticals, Llc |
Kompozycje 1-(4-bromo-5-(1-etylo-7-(metyloamino)-2-okso-1,2-dihydro-1,6-naftyrydyn-3-ylo)-2-fluorofenylo)-3-fenylomocznika
|
|
MX2022009367A
(es)
|
2020-01-29 |
2022-10-27 |
Foghorn Therapeutics Inc |
Compuestos y usos de estos.
|
|
EP4119553A4
(en)
|
2020-03-13 |
2023-12-20 |
TYK Medicines (Zhengzhou), Inc. |
Compound used as kinase inhibitor and use thereof
|
|
US11407737B2
(en)
|
2020-09-18 |
2022-08-09 |
Kinnate Biopharma Inc. |
Inhibitors of RAF kinases
|
|
TW202229239A
(zh)
|
2020-09-23 |
2022-08-01 |
日商武田藥品工業股份有限公司 |
作為ｒｉｐｋ２抑制劑之３－（６－胺基吡啶－３－基）苯甲醯胺衍生物
|
|
WO2022081469A1
(en)
|
2020-10-12 |
2022-04-21 |
Kinnate Biopharma Inc. |
Inhibitors of raf kinases
|
|
EP4251152A1
(en)
|
2020-11-25 |
2023-10-04 |
Deciphera Pharmaceuticals, LLC |
Pyridylpyridone derivatives as vsp34 inhibitors for use in the treatment of a viral infection
|
|
EP4251165A1
(en)
|
2020-11-25 |
2023-10-04 |
Deciphera Pharmaceuticals, LLC |
Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection
|
|
CA3199999A1
(en)
|
2020-11-25 |
2022-06-02 |
Deciphera Pharmaceuticals, Llc |
Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection
|
|
CN117241800A
(zh)
|
2020-11-25 |
2023-12-15 |
德西费拉制药有限责任公司 |
Vps34抑制剂的抗病毒活性
|
|
WO2022115549A1
(en)
|
2020-11-25 |
2022-06-02 |
Deciphera Pharmaceuticals, Llc |
Anti-viral activity of vps34 inhibitors
|
|
US20220184077A1
(en)
|
2020-11-25 |
2022-06-16 |
Deciphera Pharmaceuticals, Llc |
Anti-viral activity of vps34 inhibitors
|